Entering text into the input field will update the search result below

Syndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q4 2019 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q4 2019 Results Earnings Conference Call March 3, 2020 4:30 PM ET

Company Participants

Claudia Styslinger - Argot Partners

Briggs Morrison - Chief Executive Officer

Rick Shea - Chief Financial Officer

Michael Metzger - President and Chief Operating Officer

Michael Meyers - Chief Medical Officer

Conference Call Participants

Madhu Kumar - Baird

Bert Hazlett - BTIG

Ed White - H. C. Wainwright

David Lebowitz - Morgan Stanley

Joel Beatty - Citi

Jackson Harvey - Nomura Instient


Good day, everyone. And welcome to Syndax Fourth Quarter 2019 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Claudia Styslinger of Argot Partners. Please begin.

Claudia Styslinger

Thank you, operator. Welcome, and thank you to those of you joining us on the line and the webcast this afternoon for a review of Syndax's fourth quarter and full year 2019 financial and operating results.

I’m Claudia Steinwender with Argot Partners. And with me this afternoon to discuss the results and provide an update on the company's progress are, Dr. Briggs Morrison, Chief Executive Officer and Rick Shea, Chief Financial Officer. Also joining us on the call today for the question-and-answer session are Michael Metzger, President and Chief Operating Officer and Dr. Michael Meyers, Chief Medical Officer.

This call is being accompanied by Syndax that has been posted on the company's Web site. So I would ask you to please turn to our forward-looking statements on Slide 2. Before we begin, I would like to remind you that any statements made during this call that are not historical are considered to be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995.

Actual results may differ materially from those indicated by these statements as a result

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About SNDX

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on SNDX

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.